secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oric Pharmaceuticals, Inc. (ORIC)
CIK:        0001796280
Form:       8-K
Filed at:   2022-03-21T23:59:59+00:00
Accession:  0001193125-22-080683
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ORIC Pharmaceuticals hosts Q4/FY2021 call; corporate presentation furnished as Exhibit 99.1
--------------------------------------------------------------------------------

- Company held conference call on March 21, 2022 to discuss Q4 and full year 2021 financial results and operational update.
- Corporate presentation attached as Exhibit 99.1 but specific financial figures are not included in the filing text.
- Filing under Item 7.01 Regulation FD; presentation is furnished, not filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1796280/000119312522080683/0001193125-22-080683-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1796280/000119312522080683/d337066d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-080683

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer